Paraplatin and Temaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paraplatin (carboplatin) and Temaz (temazepam). Common drug interactions include alopecia among females.

The phase IV clinical study analyzes what interactions people have when they take Paraplatin and Temaz. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Paraplatin?

Paraplatin has active ingredients of carboplatin. eHealthMe is studying from 12,392 Paraplatin users. Check the latest studies of Paraplatin.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

30 people who take Paraplatin and Temaz together, and have interactions are studied.

What are the common drug interactions of Paraplatin and Temaz, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Hair colour changes
Hypersensitivity
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Mucosal inflammation (infection of mucous membrane)
Oropharyngeal pain
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Urinary tract infection
Blood creatinine increased
Eosinophil count decreased

male:

n/a

What are the common drug interactions of Paraplatin and Temaz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Alopecia (absence of hair from areas of the body)
Anxiety
Emotional distress
Pain
Psychological trauma

50-59:

Alopecia (absence of hair from areas of the body)
Dyspnoea (difficult or laboured respiration)
Psychological trauma
Blood creatinine increased
Eosinophil count decreased
Haematocrit decreased
Haemoglobin decreased
Lymphocyte count decreased
Malaise (a feeling of general discomfort or uneasiness)
Malignant neoplasm progression (cancer tumour came back)

60+:

Alopecia (absence of hair from areas of the body)
Hair colour changes
Adverse drug reaction
Arrhythmia (irregular heartbeat)
Emotional distress
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Hair disorder
Dehydration (dryness resulting from the removal of water)
Dysphagia (a condition in which swallowing is difficult or painful)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the existing conditions these people have? *

Breast Cancer Female: 8 people, 26.67%
Breast Cancer: 8 people, 26.67%
Breast Cancer Stage Ii: 4 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Paraplatin and Temaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously